1,019
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial

, , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

David E. Wallace, Michael A. Horberg, Debra A. Benator, Alan E. Greenberg, Amanda D. Castel, Anne K. Monroe & Lindsey Powers Happ. (2021) Diabetes mellitus control in a large cohort of people with HIV in care-Washington, D.C.. AIDS Care 33:11, pages 1464-1474.
Read now

Articles from other publishers (12)

Leo Benning, Julian Krehl & Felix Patricius Hans. (2023) Diabetes mellitus in der Akut- und Notfallmedizin. Notfallmedizin up2date 18:01, pages 45-62.
Crossref
Mohammed SiddiquiT.J. MooreDustin M. LongGreer A. BurkholderAmanda Willig, Christina WyattSonya HeathPaul MuntnerEdgar Turner Overton. (2022) Risk Factors for Incident Hypertension Within 1 Year of Initiating Antiretroviral Therapy Among People with HIV. AIDS Research and Human Retroviruses 38:9, pages 735-742.
Crossref
Musaab Ahmed, Marium Ahmed, Dushyant Mital & Mohamed H. Ahmed. 2022. Cholesterol. Cholesterol 999 1020 .
Violet Dismas Kajogoo, Mary Gorret Atim, Demeke Amare, Melka Geleta, Yilkal Muchie, Hanna Amanuel Tesfahunei, Willyhelmina Olomi, Joan Acam & Tsegahun Manyazewal. (2021) HIV Protease Inhibitors and Insulin Sensitivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology 12.
Crossref
Leonardo Calza, Vincenzo Colangeli, Marco Borderi, Simona Coladonato, Beatrice Tazza, Isabella Bon, Maria Carla Re & Pierluigi Viale. (2019) Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients. Journal of Antimicrobial Chemotherapy 74:3, pages 731-738.
Crossref
Gary Fong, Erik W. Skoglund, Kady Phe, Jessica Guastadisegni, Katherine M. Shea, Patrick M. McDaneld, Katherine K. Perez & Amelia K. Sofjan. (2017) Significant Publications on Infectious Diseases Pharmacotherapy in 2016. Journal of Pharmacy Practice 31:5, pages 469-480.
Crossref
F. S. Mirza, P. Luthra & L. Chirch. (2018) Endocrinological aspects of HIV infection. Journal of Endocrinological Investigation 41:8, pages 881-899.
Crossref
Todd Hulgan. (2018) Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update. Current HIV/AIDS Reports 15:3, pages 223-232.
Crossref
Ó. Moreno-Pérez, L. Giner, S. Reus, V. Boix, R. Alfayate, R. Frances, E. Merino, A. Pico & J. Portilla. (2017) Impact of circulating bacterial DNA in long-term glucose homeostasis in non-diabetic patients with HIV infection: cohort study. European Journal of Clinical Microbiology & Infectious Diseases 37:2, pages 313-318.
Crossref
Janessa M. Smith & Charles Flexner. (2017) The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development. AIDS 31:Supplement 2, pages S173-S184.
Crossref
Lemuel R. Non, Gerome V. Escota & William G. Powderly. (2017) HIV and its relationship to insulin resistance and lipid abnormalities. Translational Research 183, pages 41-56.
Crossref
Amanda L. Willig & Edgar Turner Overton. (2016) Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence. Current HIV/AIDS Reports 13:5, pages 289-296.
Crossref